Flying The Web For News.
  • Happy Holidays
    Happy Holidays
  • Career Exam Study
    Career Exam Study
  • 2024 Presidential Election
    2024 Presidential Election
  • E-commerce Guide
    E-commerce Guide
  • Dropshipping Guide
    Dropshipping Guide
  • Microsoft Exam
    Microsoft Exam
  • IT Career News
    IT Career News
+ Larger Font | - Smaller Font
Share

Globe NewsWire News Distribution Service


INTEGRIS-PSC featured in an oral late breaker presentation SOUTH SAN FRANCISCO, Calif., Nov. 18, 2024 (GLOBE NEWSWIRE) -- Pliant Therapeutics, Inc. (Nasdaq: PLRX), a late-stage biotechnology company and leader in the discovery and development of novel therapeutics for the treatment of fibrotic diseases, today announced the presentation of clinical data at The Liver Meeting® 2024…


Posted: 2024-11-18 23:00:00

Get Full News Story On GlobeNewsWire Press Release Service



Listen to this article. Speaker link opens in a new window.
Text To Speech BETA Test Version.



Related News Stories From The Web And More

Related Bing News Search Results

Press Release: Pliant Therapeutics Presents Data from its Bexotegrast Program at The Liver Meeting® 2024 - Newscast

Pliant Therapeutics Presents Data from its Bexotegrast Program at The Liver Meeting® 2024

Mon, 18 Nov 2024 15:00:00 GMT performance or achievements of Pliant Therapeutics could differ materially from those described in or implied by the statements in this press release. These forward-looking statements are subject ...

Pliant Therapeutics Presents Data from its Bexotegrast Program at The Liver Meeting® 2024

Mon, 18 Nov 2024 10:00:00 GMT SOUTH SAN FRANCISCO, Calif., Nov. 18, 2024 (GLOBE NEWSWIRE) -- Pliant Therapeutics, Inc. (Nasdaq: PLRX), a late-stage biotechnology company and leader in the discovery and development of novel ...

Pliant Therapeutics Provides Corporate Update and Reports Third Quarter 2024 Financial Results

Thu, 07 Nov 2024 14:15:00 GMT performance or achievements of Pliant Therapeutics could differ materially from those described in or implied by the statements in this press release. These forward-looking statements are subject to ...

Pliant Therapeutics Provides Corporate Update and Reports Third Quarter 2024 Financial Results

Thu, 07 Nov 2024 13:05:00 GMT Nov. 07, 2024 (GLOBE NEWSWIRE) -- Pliant Therapeutics, Inc. (Nasdaq: PLRX), a late-stage clinical biotechnology company and leader in the discovery and development of novel therapeutics for the ...




Blow Us A Whistle